Table 3. Potential for the two- and three-condition experimental design to detect relationships between placebo and experimental conditions, and true baseline values. Data are means (±1 SD).
| RMS Comparison |
Time Period |
vhip (cm·s-1) |
ωankle (°·s-1) |
| WR2W-RMSmin |
1-20 |
6.0 (1.8) |
37.0 (12.0) |
|
20-40 |
6.1 (3.0) |
22.5 (7.7) |
|
40-60 |
3.3 (1.4) |
30.3 (12.6) |
|
60-80 |
5.0 (1.7) |
41.5 (24.4) |
|
80-100 |
4.5 (1.4) |
26.1 (21.5) |
| WR2R-RMSmin |
1-20 |
5.0 (2.5) |
21.2 (11.1) |
|
20-40 |
5.6 (2.4) |
31.3 (9.8) |
|
40-60 |
6.0 (2.5) |
27.5 (10.5) |
|
60-80 |
7.6 (3.8) |
28.3 (7.8) |
|
80-100 |
4.9 (2.5) |
19.6 (8.4) |
| WR2W-RMSmin |
1-20 |
3.1 (1.9) |
19.5 (11.3) |
|
20-40 |
3.2 (1.7) |
12.3 (9.4) |
|
40-60 |
3.9 (2.2) |
22.4 (12.3) |
|
60-80 |
6.7 (4.9) |
44.0 (20.6) |
|
80-100 |
8.7 (4.2) * |
30.5 (14.1) |
| WR2R-RMSmin |
1-20 |
44.6 (11.1) † |
76.1 (40.5) † |
|
20-40 |
33.3 (7.6) † |
153.9 (45.8) † |
|
40-60 |
31.4 (8.6) † |
148.2 (43.8) † |
|
60-80 |
19.7 (7.7) † |
123.8 (56.5) † |
|
80-100 |
15.1 (12.3) † |
45.0 (9.2) † |
* Value is significantly greater than W-RMS (p < 0.05).† Value is significantly greater than R-RMS (p < 0.05).
